Stanford University

Running trials

• Not yet recruiting

  Prenatal Transplantation for Fetuses With Fanconi Anemia

  NCT07408583· Phase 1/2· Source

• Not yet recruiting

  Vagus Nerve Stimulation to Enhance Memory in Aging

  NCT07214194· Source

• Recruiting

  Stanford Healthy Goals Study

  NCT07839832· Source

• Not yet recruiting

  Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism

  NCT07635862· Phase 2· Source

• Not yet recruiting

  Hyaluronidase Injections for Sclerodactyly in Patients With Scleroderma

  NCT07916324· Phase 2· Source

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· Source

• Not yet recruiting

  Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease

  NCT07646652· Source

• Recruiting

  Animated Storytelling to Promote Colorectal Cancer Screening

  NCT07522177· Source

• Not yet recruiting

  Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke

  NCT07735338· Source

• Recruiting

  Ultrasonic Debris Clearance to Promote Brain Resilience

  NCT07573982· Source

• Not yet recruiting

  Cilostazol for Prevention of Recurrent Stroke Trial

  NCT07174414· Phase 3· Source

• Not yet recruiting

  Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

  NCT07808385· Source

• Not yet recruiting

  Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

  NCT07218575· Phase 2/3· Source

• Not yet recruiting

  Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging

  NCT04662554· Source

• Recruiting

  Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

  NCT06836479· Source

• Recruiting

  Dose-Escalation Study of Artesunate Patients With IPF

  NCT05988463· Phase 1· Source

• Recruiting

  GBPDC: Gut-Brain in PD Consortium Master Protocol

  NCT07567794· Source

• Not yet recruiting

  Study of Psilocybin Under Anesthesia Controlled by EEG

  NCT07479550· Phase 2· Source

• Not yet recruiting

  Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

  NCT07601295· Phase 2· Source

• Not yet recruiting

  Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression

  NCT07528157· Source

• Recruiting

  Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial

  NCT07339202· Source

• Active, not recruiting

  Vital Signs Blood Pressure Trial

  NCT06272318· Source

• Recruiting

  A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

  NCT06872112· Phase 1· Source

• Recruiting

  Online Pivotal Response Treatment Training in Autism Spectrum Disorder

  NCT06523387· Source

• Not yet recruiting

  Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke

  NCT05490277· Source

• Not yet recruiting

  MOBoxy: MoblO2 to Maintain Oxygenation

  NCT07222592· Source

• Recruiting

  Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

  NCT07217704· Phase 3· Source

• Recruiting

  Optimizing Brain Excitability in Depression

  NCT07242105· Source

• Not yet recruiting

  Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism

  NCT06058104· Source

• Recruiting

  Post Prandial Individual Responses to Different Foods

  NCT06989164· Source

• Recruiting

  Brain Stimulation to the Hippocampus in Schizophrenia

  NCT07010614· Source

• Recruiting

  Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

  NCT07188623· Source

• Not yet recruiting

  Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients

  NCT05558189· Source

• Active, not recruiting

  Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended

  NCT07308860· Source

• Recruiting

  XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

  NCT06895070· Source

• Enrolling by invitation

  A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

  NCT07038447· Phase 1· Source

• Enrolling by invitation

  Induction of Dreaming With EEG and Anesthesia in Healthy Adults

  NCT07198711· Phase 1· Source

• Recruiting

  Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

  NCT06736379· Phase 1· Source

• Recruiting

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· Phase 3· Source

• Recruiting

  Sleep TMS for Depression

  NCT06824415· Source

• Not yet recruiting

  Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population

  NCT06029686· Source

• Not yet recruiting

  Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease

  NCT05545826· Source

• Recruiting

  A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

  NCT06950034· Phase 1· Source

• Recruiting

  Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

  NCT06627205· Source

• Not yet recruiting

  Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

  NCT06028477· Source

• Recruiting

  Parent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children

  NCT06472115· Source

• Active, not recruiting

  Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

  NCT06712407· Phase 4· Source

• Recruiting

  Effect of Statins on Crohn's Disease

  NCT06538649· Early phase 1· Source

• Not yet recruiting

  Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention

  NCT06682351· Phase 4· Source

• Recruiting

  Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

  NCT06401577· Source

Showing 50 of 122.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Autism11 recruiting
• Depression8 recruiting
• Atrial fibrillation6 recruiting
• Parkinson disease6 recruiting
• Obesity5 recruiting
• Stroke5 recruiting
• Alzheimer disease4 recruiting
• Childhood cancers4 recruiting
• Heart failure4 recruiting
• Lung cancer4 recruiting
• Type 1 diabetes4 recruiting
• Type 2 diabetes4 recruiting
• Acute myeloid leukaemia3 recruiting
• Head and neck cancer3 recruiting
• High blood pressure3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Chronic kidney disease2 recruiting
• Colorectal cancer2 recruiting
• Coronary artery disease2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Gastric and oesophageal cancer2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Mantle cell lymphoma2 recruiting
• Pancreatic cancer2 recruiting
• Schizophrenia2 recruiting
• Systemic sclerosis (scleroderma)2 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Bladder cancer1 recruiting
• Chronic myeloid leukaemia1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• Epilepsy1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Kidney cancer1 recruiting
• Lewy body dementia1 recruiting
• Lupus (SLE)1 recruiting
• Mesothelioma1 recruiting
• Multiple sclerosis1 recruiting
• Ovarian cancer1 recruiting
• Prostate cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

  NCT07325461· Source

• Recruiting

  A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  NCT06793397· Phase 3· Source

• Completed

  BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes

  NCT05488119· Source

• Withdrawn

  Augmented Reality-based Telerehabilitation Platform for Patients With Stroke

  NCT06963645· Source

• Withdrawn

  Prediabetes Stratification by Multi-omics Profile After Food Intake

  NCT06005051· Source

• Completed

  Food Is Medicine for Patients With Heart Failure

  NCT06540118· Source

• Completed

  RECOVER-ENERGIZE Platform Protocol

  NCT06404047· Source

• Withdrawn

  Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations

  NCT06080165· Phase 1/2· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Source

• Completed

  Behavioral and Neuronal Correlates of Human Mood States

  NCT06159595· Source

• Completed

  The Pediatric Artificial Pancreas Automated Initialization Trial

  NCT06017089· Source

• Terminated

  STOP-T1D Low-Dose (ATG)

  NCT04291703· Phase 2· Source

• Completed

  RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms

  NCT05965752· Source

• Completed

  Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring

  NCT05935514· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Source

• Terminated

  64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

  NCT05633160· Phase 1/2· Source

• Completed

  Evaluating a Type 2 Diabetes Prevention Program

  NCT05822648· Source

• Withdrawn

  Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

  NCT04756765· Phase 2· Source

• Terminated

  Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep

  NCT05413928· Source

• Completed

  Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

  NCT05624268· Phase 3· Source

• Completed

  Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression

  NCT05224063· Source

• Terminated

  A Study to Investigate LYL845 in Adults With Solid Tumors

  NCT05573035· Phase 1· Source

• Completed

  Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

  NCT05234944· Source

• Completed

  A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

  NCT05453578· Phase 1/2· Source

• Completed

  64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

  NCT05407311· Phase 2· Source

• Terminated

  Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

  NCT05224661· Source

• Completed

  A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

  NCT05218655· Phase 3· Source

• Terminated

  Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

  NCT04788043· Phase 2· Source

• Completed

  Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging

  NCT04981223· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Withdrawn

  Feasibility of Mobile Game System for Potential Treatment of Developmental Delays

  NCT04909710· Source

• Completed

  Closed-loop Optimized rTMS for Depression

  NCT04142320· Phase 1· Source

• Completed

  Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

  NCT04474353· Phase 1· Source

• Terminated

  Sjogren's Lung Study

  NCT04843345· Source

• Withdrawn

  Pilot Study of 89-Zr Panitumumab in Pancreas Cancer

  NCT04833959· Phase 1· Source

• Completed

  Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

  NCT04672655· Source

• Completed

  Insul-In This Together Program for Adolescents With Type 1 Diabetes and Their Parents

  NCT04589689· Source

• Completed

  Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

  NCT04300920· Phase 3· Source

• Completed

  A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

  NCT04279613· Phase 1· Source

• Completed

  Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer

  NCT04389918· Source

• Terminated

  A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

  NCT04378075· Phase 2/3· Source

• Completed

  Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

  NCT04552769· Phase 2· Source

• Completed

  Ertugliflozin: Cardioprotective Effects on Epicardial Fat

  NCT04167761· Early phase 1· Source

• Completed

  Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test

  NCT03893500· Source

• Completed

  Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

  NCT04380337· Phase 2· Source

• Completed

  Neonatal Seizure Registry - Developmental Functional EValuation

  NCT04337697· Source

• Completed

  Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

  NCT03961971· Phase 1· Source

• Withdrawn

  Does rTMS Induce Synaptic Plasticity?

  NCT04311619· Phase 1· Source

• Completed

  Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

  NCT04042467· Source

• Completed

  Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic Feedback

  NCT04043403· Source

Showing 50 of 65.